首页> 外文期刊>Bone marrow transplantation >Acute myelogenous leukemia in a donor after granulocyte colony-stimulating factor-primed peripheral blood stem cell harvest.
【24h】

Acute myelogenous leukemia in a donor after granulocyte colony-stimulating factor-primed peripheral blood stem cell harvest.

机译:粒细胞集落刺激因子引发的外周血干细胞收获后,供体中的急性骨髓性白血病。

获取原文
获取原文并翻译 | 示例
       

摘要

This article describes the first case of acute myeloid leukemia (AML) in a healthy donor at 14 months after granulocyte colony-stimulating factor (G-CSF)-primed peripheral blood stem cell (PBSC) harvest. In September 2001, a healthy 61-year-old female was given G-CSF prior to PBSC harvest for her brother with multiple myeloma. In spite of successful engraftment, the recipient died from a disease relapse. In November 2002, the donor, admitted with high fever and leukocytosis with 98.5% blastoid cells, was diagnosed as having AML (M1). Her leukemia cells were positive for CD13, CD33, and G-CSF receptor without chromosomal abnormality and responded to G-CSF in vitro. During chemotherapy, she died of progressive pneumonia. If our case is truly the first, the incidence of leukemia in donors may not be higher than that of naturally occurring leukemia. However, efforts towards an international long-term study, or at least to report every case similar to ours, would be required to be conclusive.
机译:本文介绍了在粒细胞集落刺激因子(G-CSF)引发的外周血干细胞(PBSC)收获后14个月的健康捐献者中的第一例急性髓细胞性白血病(AML)。 2001年9月,一名健康的61岁女性在其多发性骨髓瘤的哥哥接受PBSC收获之前接受了G-CSF的治疗。尽管成功植入,受体仍因疾病复发而死亡。 2002年11月,承认患有高烧和白细胞增多症并具有98.5%的胚泡细胞的供体被诊断患有AML(M1)。她的白血病细胞对CD13,CD33和G-CSF受体呈阳性,无染色体异常,体外对G-CSF有反应。在化疗期间,她死于进行性肺炎。如果我们的情况确实是第一个,那么捐献者中的白血病发病率可能不会高于自然发生的白血病。但是,将需要作出结论性的努力,即进行国际长期研究,或者至少报告与我们类似的每一个病例。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号